Labshake search
Citations for Bio X Cell :
1 - 50 of 519 citations for 8 4 ethoxy 3 methoxyphenyl 1 5 diazabicyclo 3.2.1 octane since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 5 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Immunology 2022Quote: ... anti–mIL-4 (8 μg/mL, Bio X Cell), and anti–mIFN-γ (8 μg/mL ...
-
bioRxiv - Immunology 2021Quote: ... anti–mIL-4 (8 μg/mL, Bio X Cell), and anti–mIFN-γ (8 μg/mL ...
-
bioRxiv - Immunology 2019Quote: ... αIL-4 (5 μg mL−1, clone 11B11; Bio X Cell), rhTGF-β1 (2 ng mL−1 ...
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 4 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Cancer Biology 2021Quote: ... anti-4-1BB agonist (5 mg/kg, clone: 3H3, BioXcell), or anti-PD-1 (10 mg/kg ...
-
bioRxiv - Cancer Biology 2023Quote: ... anti-TIM3 Ab (4 μg/ml, clone RMT-3-23, BioXCell, Lebanon, NH), or 25-hydroxycholesterol (4 μM ...
-
bioRxiv - Immunology 2023Quote: ... injections every 3-4 days with 200 µg irrelevant antibody (clone 2A3, BioXCell), αPD-1 (clone RMP1-14 ...
-
bioRxiv - Cancer Biology 2021Quote: Mice were treated with either IgG (5 mg/kg as an anti-4-1BB control, 10 mg/kg as an anti-PD-1 control, BioXcell), anti-4-1BB agonist (5 mg/kg ...
-
bioRxiv - Immunology 2021Quote: Intraperitoneal injections of αPDL1 (200 μg/injection on days 4, 8, 14, and 18; clone 10F.9G2; BioXcell), and HMGN1 and its-derived peptdies (0.08 μg on days 9 ...
-
bioRxiv - Immunology 2023Quote: ... or 4-1BB (5 µg/ml, clone 3H3, BE0239) all from BioXCell. Unless otherwise stated ...
-
bioRxiv - Cancer Biology 2024Quote: ... and/or 5 mg/kg anti-CTLA-4 (clone 9H10, cat. BE0131, BioXcell). Antibodies were dissolved in PBS and administered via intraperitoneal injection (4 μl/g ...
-
bioRxiv - Immunology 2023Quote: ... and 5 ug JES6-1 (BioXcell) intraperitoneally on days 2-4 post-infection in a total volume of 200 uL ...
-
bioRxiv - Cancer Biology 2020Quote: ... intraperitoneal anti-CD-8 (Bio X Cell® BE0004-1 Clone 53-6.72) or control antibody was injected at a dose of 10 mg/kg on days 0 ...
-
bioRxiv - Immunology 2022Quote: ... ∼3-5×107 thymocytes were incubated with 20 μg anti-CD4 (rat IgG2b clone GK1.5, BioXCell) and 37.5 μg anti-CD8a (rat IgG2a clone 53-6.72 ...
-
bioRxiv - Immunology 2022Quote: ... 5 ug/ml Brefeldin A was supplemented 4 hrs before subsequent Fc blocking (2.4G2, BioXCell), surface antibody staining ...
-
bioRxiv - Immunology 2023Quote: ... or Th17 – rhTGFβ (3 ng mL-1, Miltenyi) + rmIL-6 (20 ng mL-1, Miltenyi) + anti-IFNγ (10 μg mL-1, BioXcell). Cells were then transferred to uncoated tissue culture plates and cultured for an additional 3 days ...
-
bioRxiv - Immunology 2021Quote: ... Jedi T cells were activated for 3 days with 5 mg/ml plate-bound anti-CD3 mAb (clone 2C11, BioXCell), 1 mg/ml anti-CD28 mAb (clone 37.51 ...
-
bioRxiv - Immunology 2020Quote: ... were polarized into Th1 cells for 3 days using plate-bound anti-CD3 (5 µg/ml, clone 145-2C11, BioXCell), anti-CD28 (1 µg/ml ...
-
bioRxiv - Immunology 2020Quote: ... and/or human CD8α (Bioxcell, OKT-8) three days prior to first treatment and concurrently with subsequent treatments.
-
bioRxiv - Immunology 2023Quote: NK cells were depleted from C57BL/6 mice starting at 3-4 weeks of age by intraperitoneal injection of 200 µg of anti-NK1.1 mAb (clone PK136, Bio X Cell) every 5 days for 3 weeks.
-
bioRxiv - Immunology 2022Quote: ... or combination of PD-1 and CTLA-4 using anti-PD-1 (clone: RMP1-14, BioXcell), anti-CTLA-4 (clone ...
-
bioRxiv - Cancer Biology 2022Quote: ... anti-PD-1 (5 mg/kg, #BE0273, BioXCell, twice per week), abraxane (25 mg/kg ...
-
bioRxiv - Cancer Biology 2023Quote: ... 100μg/mouse anti-CD28 (clone PV-1, BioXcell, Cat#BE0015-5) or isotype (polyclonal Armenian hamster Armenian Hamster IgG ...
-
bioRxiv - Microbiology 2021Quote: ... 10 μg·ml-1 anti-IL-4 and 10 μg·ml-1 anti-IL-2 (Bio X Cell, Cat# BE0043-1, RRID:AB_1107705). For Treg cell differentiation ...
-
bioRxiv - Cell Biology 2020Quote: ... 8 and 11 anti-CTLA4 antibody (9H10; BioXCell) was administered interperitoneally at 200 μg per mouse ...
-
bioRxiv - Immunology 2022Quote: ... cells were stained with anti-human ICAM-1-AlexaFluor647 (BioXcell, BE0020-2, 3 µM), anti-human CD58-AlexaFluor647 (BD Bioscience ...
-
bioRxiv - Cancer Biology 2021Quote: ... 250 μg PD-1 and CTLA-4 blocking (clone 9H10, BioXCell, Lebanon, NH) antibodies were injected intraperitoneally thrice per week for four weeks or a combination of PD-1 CTLA-4 antibodies with iBET762 were used.
-
bioRxiv - Immunology 2023Quote: ... mice were randomized into different groups and were treated with anti-PD-1 (5 mg/kg, clone RMP1-14, ichorbio IHC1132) or isotype control Rat IgG2a (5 mg/kg, clone 2A3, BioXcell BE0089) twice per week for two weeks ...
-
bioRxiv - Immunology 2019Quote: ... with 5 μg purified anti-mouse IL-2 antibody (JES6-1, BioXcell) for 30 min at 37°C (molar ratio for IL2:anti-IL-2 is 2:1) ...
-
bioRxiv - Immunology 2022Quote: ... anti–mIL-2 (8 μg/mL, Bio X Cell), anti–mIL-4 (8 μg/mL ...
-
bioRxiv - Immunology 2021Quote: ... anti–mIL-2 (8 μg/mL, Bio X Cell), anti–mIL-4 (8 μg/mL ...
-
bioRxiv - Immunology 2023Quote: ... or control IgG (n=8) (Syrian hamster IgG BioXCell), following the protocol depicted in Fig 4A.
-
bioRxiv - Cancer Biology 2021Quote: ... 3) 10 µg/kg anti-PD-1 mAb (BioXCell, Cat. No. BE0146, clone RMP1-14) IP every three days for the duration of the experiment ...
-
bioRxiv - Immunology 2020Quote: ... each of anti-LFA-1 and anti-VLA-4 blocking antibodies (Bio X Cell) or control IgG ...
-
bioRxiv - Immunology 2023Quote: ... into Th1 cells – 10 ng mL-1 rmIL-12 (R&D Biosystems) plus anti-IL-4 (10 μg mL-1, BioXcell), or Th17 – rhTGFβ (3 ng mL-1 ...
-
bioRxiv - Immunology 2022Quote: ... and anti–mIFN-γ (8 μg/mL, Bio X Cell) (TH17 differentiation) ...
-
bioRxiv - Immunology 2021Quote: ... and anti–mIFN-γ (8 μg/mL, Bio X Cell) for TH17 differentiation ...
-
bioRxiv - Cancer Biology 2024Quote: ... Anti-murine PD-1 and anti-murine CTLA-4 were purchased from Bio X Cell (BE0146-clone RMP1-14 ...
-
bioRxiv - Immunology 2022Quote: ... Cells were subsequently washed twice with PBS and incubated with anti-human ICAM-1-AlexaFluor647 (BioXcell, BE0020-2, 3 µM, 1:500 dilution) for 30 min at room temperature ...
-
bioRxiv - Immunology 2023Quote: ... with the monoclonal antibody against human CD8 (clone OKT-8; BioXCell). The initial injection was 75 µg ...
-
bioRxiv - Immunology 2021Quote: ... CTLs were pre-incubated with LFA-1 blocking antibody (20 μg/mL, Clone M17/4, BioXCell) or an IgG2aκ isotype control antibody (20 μg/mL ...
-
bioRxiv - Immunology 2024Quote: ... Cells were activated by TCR stimulation using plate-bound human anti-CD3 and soluble CD28 (clone OKT-3 and clone 9.3 Bio X Cell, respectively, 5 μg/mL of each) for 3 days ...
-
bioRxiv - Immunology 2023Quote: ... and 8 post-infection with 200 ug of αCD8 (Clone 2.43 BioXcell) or control IgG antibody in 200 uL PBS (PMID ...
-
bioRxiv - Immunology 2023Quote: ... 555-TS-010) and agonistic antibodies for GITR (5 µg/ml, clone DTA-1, BioXCell, BE0063), OX40 (5 µg/ml ...
-
bioRxiv - Microbiology 2021Quote: ... naïve CD4+ T cells were cultured with 10 ng·ml-1 IL-12 (R&D, Cat# 402-ML-020/CF) and 10 μg·ml-1 anti-IL-4 (Bio X Cell, Cat# BE0045, RRID:AB_1107707). For Th17 cell differentiation ...
-
bioRxiv - Immunology 2021Quote: ... and anti-IL-4 (BioXCell); for Th2 ...
-
bioRxiv - Cancer Biology 2022Quote: ... and anti-mouse PD-1 antibodies (clone RMP1-14, 10 mg/kg, 6 doses, every 3 days) were purchased from BioXcell. All drug treatments were administered intraperitoneally (i.p.).
-
bioRxiv - Cancer Biology 2023Quote: ... mice were treated intraperitoneally every 3 days with either 1 mg/kg ADU-S100 and 200 µg anti-PD1/isotype (BioXcell) or with 20 mg/kg MCC950 ...
-
bioRxiv - Immunology 2022Quote: ... Tim-3 was neutralized using InVivoMAb anti-mouse Tim-3 antibodies (10µg/mL) (Bio X Cell, Lebanon, NH) for 1 h prior to rBma-LEC-1 or rBma-LEC-2 treatment.